(UroToday.com) The SUO 2025 Annual Meeting featured a poster presentation by Dr. Mark Tyson reporting preliminary findings from Cohort A of the ADVANCED-2 trial, an ongoing phase II, open-label trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback